Reducing Suicidal Ideation Through Treatment of Nightmares-Post Traumatic Stress Disorder (PTSD)
| Status: | Completed |
|---|---|
| Conditions: | Insomnia Sleep Studies, Psychiatric, Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 9/20/2018 |
| Start Date: | March 2014 |
| End Date: | December 1, 2017 |
Reducing Suicidal Ideation Through Treatment of Nightmares-PTSD
Patients with PTSD, and frequent nightmares, and mild-moderate suicidal ideation, who are
already taking a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine
Reuptake Inhibitor (SNRI) will be randomized to either prazosin or placebo. The investigators
hypothesize that patients receiving prazosin will have a greater reduction in suicidal
ideation.
already taking a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine
Reuptake Inhibitor (SNRI) will be randomized to either prazosin or placebo. The investigators
hypothesize that patients receiving prazosin will have a greater reduction in suicidal
ideation.
Inclusion Criteria:
- PTSD
- Frequent nightmares
- Suicidality
Exclusion Criteria:
- Schizophrenia
- Bipolar
- Substance abuse
We found this trial at
1
site
Georgia Regents University Georgia Regents University, home of the Medical College of Georgia, is one...
Click here to add this to my saved trials
